235 related articles for article (PubMed ID: 23543413)
1. A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells.
Ivy KD; Kaplan JH
Mol Pharmacol; 2013 Jun; 83(6):1237-46. PubMed ID: 23543413
[TBL] [Abstract][Full Text] [Related]
2. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
[TBL] [Abstract][Full Text] [Related]
3. Overcoming platinum drug resistance with copper-lowering agents.
Chen HH; Kuo MT
Anticancer Res; 2013 Oct; 33(10):4157-61. PubMed ID: 24122978
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals.
Liang ZD; Long Y; Chen HH; Savaraj N; Kuo MT
J Biol Inorg Chem; 2014 Jan; 19(1):17-27. PubMed ID: 24132751
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic basis for overcoming platinum resistance using copper chelating agents.
Liang ZD; Long Y; Tsai WB; Fu S; Kurzrock R; Gagea-Iurascu M; Zhang F; Chen HH; Hennessy BT; Mills GB; Savaraj N; Kuo MT
Mol Cancer Ther; 2012 Nov; 11(11):2483-94. PubMed ID: 22914438
[TBL] [Abstract][Full Text] [Related]
6. The role of the methionines and histidines in the transmembrane domain of mammalian copper transporter 1 in the cellular accumulation of cisplatin.
Larson CA; Adams PL; Blair BG; Safaei R; Howell SB
Mol Pharmacol; 2010 Sep; 78(3):333-9. PubMed ID: 20519567
[TBL] [Abstract][Full Text] [Related]
7. The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin.
Larson CA; Adams PL; Jandial DD; Blair BG; Safaei R; Howell SB
Biochem Pharmacol; 2010 Aug; 80(4):448-54. PubMed ID: 20451502
[TBL] [Abstract][Full Text] [Related]
8. Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy.
Kuo MT; Fu S; Savaraj N; Chen HH
Cancer Res; 2012 Sep; 72(18):4616-21. PubMed ID: 22962276
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin.
Liang ZD; Stockton D; Savaraj N; Tien Kuo M
Mol Pharmacol; 2009 Oct; 76(4):843-53. PubMed ID: 19570948
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters.
Guo Y; Smith K; Petris MJ
J Biol Chem; 2004 Nov; 279(45):46393-9. PubMed ID: 15326162
[TBL] [Abstract][Full Text] [Related]
11. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.
Holzer AK; Samimi G; Katano K; Naerdemann W; Lin X; Safaei R; Howell SB
Mol Pharmacol; 2004 Oct; 66(4):817-23. PubMed ID: 15229296
[TBL] [Abstract][Full Text] [Related]
12. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.
Wu Z; Liu Q; Liang X; Yang X; Wang N; Wang X; Sun H; Lu Y; Guo Z
J Biol Inorg Chem; 2009 Nov; 14(8):1313-23. PubMed ID: 19669174
[TBL] [Abstract][Full Text] [Related]
13. Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1.
Chen HH; Song IS; Hossain A; Choi MK; Yamane Y; Liang ZD; Lu J; Wu LY; Siddik ZH; Klomp LW; Savaraj N; Kuo MT
Mol Pharmacol; 2008 Sep; 74(3):697-704. PubMed ID: 18523133
[TBL] [Abstract][Full Text] [Related]
14. Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1.
Jandial DD; Farshchi-Heydari S; Larson CA; Elliott GI; Wrasidlo WJ; Howell SB
Clin Cancer Res; 2009 Jan; 15(2):553-60. PubMed ID: 19147760
[TBL] [Abstract][Full Text] [Related]
15. Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy.
Chen HH; Chen WC; Liang ZD; Tsai WB; Long Y; Aiba I; Fu S; Broaddus R; Liu J; Feun LG; Savaraj N; Kuo MT
Expert Opin Ther Targets; 2015; 19(10):1307-17. PubMed ID: 26004625
[TBL] [Abstract][Full Text] [Related]
16. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
17. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1).
Du X; Wang X; Li H; Sun H
Metallomics; 2012 Jul; 4(7):679-85. PubMed ID: 22552365
[TBL] [Abstract][Full Text] [Related]
18. Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis.
Lai YH; Kuo C; Kuo MT; Chen HHW
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772714
[TBL] [Abstract][Full Text] [Related]
19. Molecular modulation of the copper and cisplatin transport function of CTR1 and its interaction with IRS-4.
Tsai CY; Larson CA; Safaei R; Howell SB
Biochem Pharmacol; 2014 Aug; 90(4):379-87. PubMed ID: 24967972
[TBL] [Abstract][Full Text] [Related]
20. Copper-dependent recycling of hCTR1, the human high affinity copper transporter.
Molloy SA; Kaplan JH
J Biol Chem; 2009 Oct; 284(43):29704-13. PubMed ID: 19740744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
